Summary
Stryker Corporation reported its first quarter 2026 results, showcasing a 2.6% increase in net sales to $6,020 million, driven by both its MedSurg and Neurotechnology segment (up 5.0%) and a marginal increase in its Orthopaedics segment (up 0.1%). While overall sales saw a modest rise, profitability faced some headwinds, with gross profit margin declining to 63.3% from 63.8% year-over-year, primarily due to increased manufacturing and supply chain costs linked to a recent cybersecurity incident. Net earnings rose to $745 million, or $1.93 per diluted share, a notable increase from $654 million, or $1.69 per diluted share, in the prior year period. Despite the challenges, including the impact of the cybersecurity incident, Stryker demonstrated resilience in its operations. The company's strategic focus on innovation and its diversified product portfolio across key medical technology areas continue to support its growth trajectory. Management highlighted a reorganization in the Ortho Tech business to enhance customer experience and speed to market. Investors will be keen to monitor the ongoing impact of the cybersecurity incident and the company's ability to navigate supply chain pressures and maintain its growth momentum in the upcoming quarters.
Financial Highlights
52 data points| Revenue | $6.02B |
| Cost of Revenue | $2.21B |
| Gross Profit | $3.81B |
| R&D Expenses | $413.00M |
| SG&A Expenses | $2.28B |
| Operating Expenses | $2.87B |
| Operating Income | $936.00M |
| Interest Expense | $142.00M |
| Net Income | $745.00M |
| EPS (Basic) | $1.95 |
| EPS (Diluted) | $1.93 |
| Shares Outstanding (Basic) | 382.90M |
| Shares Outstanding (Diluted) | 386.50M |
Key Highlights
- 1Net sales increased by 2.6% to $6.02 billion in Q1 2026 compared to $5.87 billion in Q1 2025.
- 2MedSurg and Neurotechnology segment sales grew by 5.0% to $3.21 billion, while Orthopaedics segment sales saw a modest increase of 0.1% to $2.81 billion.
- 3Gross profit margin decreased to 63.3% from 63.8% in the prior year, attributed to higher manufacturing and supply chain costs related to a cybersecurity incident.
- 4Net earnings increased by 13.9% to $745 million, with diluted EPS rising to $1.93 from $1.69.
- 5The company experienced a cybersecurity incident in Q1 2026 which disrupted operations but has since restored global manufacturing and commercial systems.
- 6Stryker repaid $1,000 million of senior unsecured notes in March 2026, reducing its long-term debt.
- 7The company announced a reorganization of its Ortho Tech business to simplify customer experience and accelerate innovation.